Company / Cash per Share
enGene Holdings Inc. Cash per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.98
FY2025
5-year range
$0.98 / $117.70
FY2022-FY2025
Trend
-78.6%
vs FY2024
Sector context
#145 of 203
Health Care
What the data says
At $0.98, enGene Holdings Inc.'s cash per share ranks #145 of 203 in the Health Care sector. Declined from $117.70 to $0.98 over the past 2 years.
Based on SEC 10-K filings.
0.98 in FY2025 with a 3-year CAGR of -68.4%.
Declined from $117.70 to $0.98 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -68.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#145 of 203 in Health CareTop 71% of 203This company $0.98 Sector average $76.43
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 78.6% year-over-year.
- Ranks #145 out of 203 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.98 | -78.6% |
| FY2024 | $4.58 | -96.1% |
| FY2023 | $117.70 | +277.4% |
| FY2022 | $31.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026